This document is an excerpt from the EUR-Lex website
Document 62017TN0103
Case T-103/17: Action brought on 17 February 2017 — Recordati Orphan Drugs v EUIPO — Laboratorios Normon (NORMOSANG)
Case T-103/17: Action brought on 17 February 2017 — Recordati Orphan Drugs v EUIPO — Laboratorios Normon (NORMOSANG)
Case T-103/17: Action brought on 17 February 2017 — Recordati Orphan Drugs v EUIPO — Laboratorios Normon (NORMOSANG)
OJ C 121, 18.4.2017, p. 41–41
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
18.4.2017 |
EN |
Official Journal of the European Union |
C 121/41 |
Action brought on 17 February 2017 — Recordati Orphan Drugs v EUIPO — Laboratorios Normon (NORMOSANG)
(Case T-103/17)
(2017/C 121/60)
Language in which the application was lodged: English
Parties
Applicant: Recordati Orphan Drugs (Puteaux, France) (represented by: J. Quirin, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Laboratorios Normon SA (Tres Cantos, Spain)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant
Trade mark at issue: EU word mark ‘NORMOSANG’ — Application for registration No 12 174 926
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 22 November 2016 in Case R 831/2016-5
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
order EUIPO to pay the costs. |
Pleas in law
|
— |
Infringement of Article 8(1)(b) of Regulation No 207/2009; |
|
— |
Infringement of Rules 19(2)(a)(ii) and 20(1) of Regulation No 2868/95. |